FDA Drugs recall ·
TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%)… recall
- Recall number
- D-0693-2026
- Date
- (initiated April 8, 2026)
- Company / brand
- Blaine Labs Inc
11037 Lockport Pl, Santa Fe Springs, CA, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 519 - 1 oz bottles
- Hazard tags
- Microbial contamination Manufacturing practices (cGMP)
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy cap, Manufactured for: Trifluent Pharma, LLC. San Antonio, TX 78213. NDC 73352-520-01.
Why was it recalled?
CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot #: BL3435, Exp. 11/06/26
Distribution
Nationwide in the USA
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0693-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.